SCHEMBL8351815

SCHEMBL8351815

COC(=CC=Cc1cn(C(C)=O)c2ccccc12)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.54
GAA P10253 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
KMT2A Q03164 9/20 0.46
MEN1 O00255 7/20 0.46
RAB9A P51151 4/20 0.45
POLB P06746 5/20 0.44
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 3/20 0.43
HPGD P15428 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CREBBP Q92793 2/20 0.42
THRB P10828 1/20 0.41
ACHE P22303 1/20 0.41
NR4A2 P43354 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8351810 1.00 MAPT (0.54) MAPTGAASMN1; SMN2KMT2AMEN1
SCHEMBL8351814 1.00 MAPT (0.54) MAPTGAASMN1; SMN2KMT2AMEN1
SCHEMBL2561497 0.79 KMT2A (0.54) MAPTGAASMN1; SMN2KMT2AMEN1
SCHEMBL2561496 0.79 KMT2A (0.54) MAPTGAASMN1; SMN2KMT2AMEN1
SCHEMBL11887857 0.77 MAPT (0.55) MAPTGAASMN1; SMN2KMT2AMEN1
SCHEMBL14570850 0.77 KMT2A (0.52) MAPTGAASMN1; SMN2KMT2AMEN1
SCHEMBL870631 0.72 KMT2A (0.59) MAPTGAASMN1; SMN2KMT2AMEN1
SCHEMBL8923713 0.72 NFE2L2 (0.58) MAPTKMT2AMEN1RAB9AKDM4E
SCHEMBL8923719 0.72 NFE2L2 (0.58) MAPTKMT2AMEN1RAB9AKDM4E
SCHEMBL8921387 0.72 MAPT (0.50) MAPTRAB9AKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5981525-A FOR THERAPY OR PROPHYLAXIS OF OSTEOPOROSIS,TUMOURS, ULCERS, AUTOIMMUNE DISEASES, LIPIDEMIC DISORDERS, HYPERCHOLESTEROLEMIC AND ATHEROSCLEROTIC DISEASES, AIDS ALZHEIMER'S DISEASE SMITHKLINE BEECHAM CORPORATION (US) 1999-11-09 US disclosed
EP-0802902-A1 INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF OSTEOPOROSIS Smithkline Beecham S.p.A. (IT) 1997-10-29 EP disclosed
WO-1996021644-A1 INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF OSTEOPOROSIS SMITHKLINE BEECHAM S.P.A. (IT) 1996-07-18 WO disclosed